Ryuji Morizane

Dr. Morizane is a physician-scientist at Massachusetts General Hospital and Harvard Medical School. He has a long-standing interest in translational research using hPSCs for kidney diseases and drug discovery. He has been working on pluripotent stem cell research since 2007 and established protocols to induce kidney lineage cells. His seminal work enabled the generation of nephron progenitor cells and kidney organoids from hPSCs with high efficiency, leading to his NIH Director’s New Innovator Award in 2019.

Education

• Doctor of Philosophy (Ph.D.) Keio University School of Medicine (2007 — 2011)
• Doctor of Medicine (M.D.) Keio University School of Medicine (1999 — 2005)

Companies

• Research Staff Massachusetts General Hospital (2019)
• Visiting Scholar Wyss Institute for Biologically Inspired Engineering (2018)
• Assistant Professor Harvard Medical School (2017)
• Affiliated Faculty Harvard Stem Cell Institute (2016)
• Associate Biologist Brigham and Women's Hospital (2015 — 2019)
• Instructor Harvard Medical School (2015 — 2017)
• Postdoctoral Researcher Brigham and Women's Hospital (2012 — 2015)
• Instructor Keio University School of Medicine (2011 — 2015)
• Research Assistant Stem cell Global COE program (2008 — 2011)